FDA Variance Approval Letter

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter addressed to Matthew Lewis. The document is marked as restricted due to Personally Identifiable Information, and a redacted version is available for download.

This variance approval indicates a specific regulatory decision related to a medical device or drug. Compliance officers should note that while the full details are restricted, the issuance of such a letter signifies a formal FDA action. Further review of the redacted document may be necessary to understand the specific conditions or implications for the regulated entity.